- Trials with a EudraCT protocol (783)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (40)
783 result(s) found for: Potassium.
Displaying page 1 of 40.
EudraCT Number: 2011-005525-48 | Sponsor Protocol Number: AK-01 | Start Date*: Information not available in EudraCT |
Sponsor Name:Diakonhjemmet hospital | ||
Full Title: Potassium infusion for conversion of atrial fibrillation/atrial flutter. | ||
Medical condition: Atrial fibrillation / atrial flutter | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000197-53 | Sponsor Protocol Number: 2011-000197-53 | Start Date*: 2011-04-15 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Effects of Potassium Sparing Diuretics on Potassium Urinary Output, Plasma Levels and Cardiac Arrhythmias in Neurocritical Care Patients Receiving Mannitol Therapy for Cerebral Edema: double blind,... | |||||||||||||
Medical condition: Acute Cerebral Edema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001738-29 | Sponsor Protocol Number: RGHT000502 | Start Date*: 2009-03-20 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: Renin angiotensin Aldosterone (RAAS) axis, endothelial function and hypertension: diagnostic strategies and therapeutic role of potassium supplementation | ||
Medical condition: We are seeking to determine the effects of potassium supplementation vs placebo for 6 weeks on the renin-angiotensin-aldosterone axis and also endothelial function in subjects with 10-20% 10 year ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003955-50 | Sponsor Protocol Number: D9480C00005 | Start Date*: 2017-12-21 | |||||||||||
Sponsor Name:AstraZeneca, AB | |||||||||||||
Full Title: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ENERGIZE) | |||||||||||||
Medical condition: Hyperkalemia requiring urgent therapy (serum potassium more than or equal to 5.8mmol/L). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000298-22 | Sponsor Protocol Number: PRENECAL | Start Date*: 2012-12-05 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Study to assess the efficacy and safety of oral potassium citrate on the Prevention of nephrocalcinosis in extreme premature: a clinical trial, randomized, double-blind placebo controlled trial. St... | |||||||||||||
Medical condition: incidence of nephrocalcinosis in extremely preterm infants | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002785-31 | Sponsor Protocol Number: RLY5016-206p | Start Date*: 2017-08-03 | |||||||||||
Sponsor Name:Vifor Pharma, Inc. | |||||||||||||
Full Title: A Phase 2, Open-Label, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer for Oral Suspension in Children and Adolescents 2 to < 18 Years of Age with... | |||||||||||||
Medical condition: Chronic Kidney Disease and Hyperkalemia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BG (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001956-20 | Sponsor Protocol Number: RLY5016-301 | Start Date*: 2013-02-11 | |||||||||||
Sponsor Name:Relypsa Inc | |||||||||||||
Full Title: A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia | |||||||||||||
Medical condition: Hyperkalemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) SI (Completed) BG (Completed) IT (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-009983-29 | Sponsor Protocol Number: RLY5016–202 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Relypsa, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Study to Evaluate the Effects of RLY5016 in Heart Failure Patients | |||||||||||||
Medical condition: Hyperkalemia in heart failure patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004460-66 | Sponsor Protocol Number: KARAASS-1 | Start Date*: 2014-04-01 | ||||||||||||||||
Sponsor Name:Jørgen Jeppesen | ||||||||||||||||||
Full Title: Oral potassium supplementation in healthy men - interactions with the renin-angiotensin-aldosterone system and the sympathetic nervous system | ||||||||||||||||||
Medical condition: Blood pressure regulation and hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-002850-69 | Sponsor Protocol Number: IGPM01 | Start Date*: 2006-01-06 |
Sponsor Name:Swansea NHS Trust | ||
Full Title: Role of High dose insulin and glucose-potassium-magnesium (HDI-GKM) for Myocardial protection in cardiac surgery | ||
Medical condition: We propose to recruit 90 patients (based on the power calculation) undergoing first time urgent in-house CABG at Morriston Hospital. The decision to operate on an urgent basis will be based on the ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002621-29 | Sponsor Protocol Number: tacpat | Start Date*: 2021-06-08 |
Sponsor Name:oslo university hospital | ||
Full Title: Effect of patiromer on pharmacokinetics of immunosuppressive drugs in renal transplant recipients | ||
Medical condition: hyperkalemia transplantation immunosuppression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001402-28 | Sponsor Protocol Number: EII_Prep | Start Date*: 2019-01-28 |
Sponsor Name:Hospital Universitario La Paz | ||
Full Title: PROTOCOL FOR THE OPTIMIZATION OF THE PREPARATION FOR THE COLONOSCOPY IN PATIENTS WITH INTESTINAL INFLAMMATORY DISEASE | ||
Medical condition: preparation in patients with inflammatory bowel disease who will undergo an endoscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004555-31 | Sponsor Protocol Number: ZS-005 | Start Date*: 2015-04-17 | |||||||||||
Sponsor Name:ZS Pharma Inc | |||||||||||||
Full Title: A Phase 3 Multicenter, Multi-dose, Open-label Maintenance Study to Investigate the Long-term Safety and Efficacy of ZS (Sodium Zirconium Cyclosilicate), an Oral Sorbent, in Subjects with Hyperkalemia | |||||||||||||
Medical condition: Hyperkalemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) NL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004418-16 | Sponsor Protocol Number: B24CS | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Advicenne SA | |||||||||||||
Full Title: A Phase 3b Open-Label Extension of Study B23CS (ARENA 2) Evaluating the Continued Safety and Efficacy of ADV7103 in Subjects With Primary Distal Renal Tubular Acidosis (ARENA 2 Open-label Extensio... | |||||||||||||
Medical condition: Distal renal tubular acidosis | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000695-38 | Sponsor Protocol Number: 2020-000695-38 | Start Date*: 2020-06-12 |
Sponsor Name:Karolinska Universitetssjukhuset | ||
Full Title: Healthy diet rich in potassium containing fruits, vegetables and nuts to chronic kidney disease patients thought the use of sodium zirconium cyclosilicate: A Feasibility Study | ||
Medical condition: Chronic kidney disease, stages 4 and 5 of the disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003312-27 | Sponsor Protocol Number: D9480C00018 | Start Date*: 2021-03-02 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: Phase IV, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Trial Evaluating Sodium Zirconium Cyclosilicate (SZC) for the Management of Hyperkalaemia in Patients with Symptomatic Heart Failur... | |||||||||||||
Medical condition: Hyperkalemia in Patients with Symptomatic Heart Failure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003527-14 | Sponsor Protocol Number: D9480C00023 | Start Date*: 2021-12-17 | |||||||||||
Sponsor Name:ASTRAZENECA AB | |||||||||||||
Full Title: An Open-Label, Randomised, Phase 4 Study of Continuing Sodium Zirconium Cyclosilicate (SZC) after Discharge in Participants with Chronic Kidney Disease treated for Hyperkalaemia | |||||||||||||
Medical condition: Patients with Chronic Kidney Disease treated for Hyperkalaemia whilst in hospital, who are normokalemic and established on maintenance dose of SZC at discharge. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) ES (Ongoing) FR (Completed) NL (Completed) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002068-42 | Sponsor Protocol Number: B14CS | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Advicenne | |||||||||||||
Full Title: Open label, multicentre study, evaluating the safety, tolerability, efficacy, compliance and the acceptability of alkalising treatments at long-term in patients with cystinuria | |||||||||||||
Medical condition: Cystinuria | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002544-24 | Sponsor Protocol Number: APHP180577 | Start Date*: 2020-01-16 |
Sponsor Name:ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS [...] | ||
Full Title: NA | ||
Medical condition: NA | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2017-003029-14 | Sponsor Protocol Number: D9480C00006 | Start Date*: 2018-02-09 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A phase 3b, multicenter, prospective, randomized, double blind, placebocontrolled study to reduce incidence of pre-dialysis hyperkalemia with Sodium Zirconium Cyclosilicate (DIALIZE) | |||||||||||||
Medical condition: Hyperkalemia among patients on stable hemodialysis (pre-dialysis serum K >5.4 mmol/L after long inter-dialytic interval and >5.0 mmol/L after one short inter-dialytic interval) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
